-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
FDA Considers Waiving Prescription Requirement for Key Drugs
The FDA is considering a proposal to waive the prescription requirement for key drugs and encourage easy access to computer-supported self-diagnostic tools.
10 Pharma Blue Chips to Buy
There are a number of great companies in pharma if you know where to look.
3 Crash-Proof Medical Stocks to Keep Your Portfolio’s Pulse
The recent rally won't last forever, but investors wanting to jump in can still do so -- and protect themselves -- by getting into these health-related equities.
4 Stocks to Watch on Dendreon Earnings
Here's a look at how to trade Dendreon on Monday's earnings report, as well as similar smaller companies that tend to move when DNDN moves.
5 Ways Alex Gorsky Can Heal Ailing J&J
Here's why Alex Gorsky, former captain in the U.S. Army Rangers, has what it takes to lead the health-care giant out of its morass.
5 Top Biotech Stocks Providing Healthy Returns
The fundamental and quantitative results from analyzing these five biotech stocks are impressive.
Why Illumina’s Future Remains Bright
Rejection of Roche's takeover bid has cooled ILMN shares, but many expect Roche to step up its advances. If not, Illumina still has great growth prospects.
2 Stocks to Watch for the Earnings Junkies
Canadian oil extractor Cenovus and international pharmaceutical company Teva announced positive earnings reports lately. See how they each stack up.
A Biotech That May Boost an Anemic Portfolio
Celgene Corp. is in an aggressive bull market and recently flashed another buy signal. Get the target for CELG.
Overreacting to a Prostate Cancer Drug?
Medivation shares are soaring on positive test results. But investors may be getting ahead of reality here.
CELG to Break Triple Digits
Celgene Corp. has flashed two buy signals in the past week. Get the target.
Amylin Gets a Boost From Its Diabetes Drug Approval
FDA approval of Bydureon -- a once-a-week injectable drug -- could make Amylin a takeover target for a Big Pharma.
Someone Has to Crunch All That Clinical Trial Data
That's where a slew of info-tech companies, ranging from giant Oracle to tiny BioClinica, come in. However, investing is them is no slam dunk.
Small Patient Population? Charge $400K a Year for Your Drug
Companies like BioMarin Pharmaceutical are cashing in on rare diseases, where they can charge hundreds of thousands of dollars every year for their drugs.
3 Health Care Plays With Healthy Dividends
These long-term picks fit the bill if you agree this sector's future is sound. Demographic trends alone make for a compelling argument.
Roche’s Hostile Bid for Illumina Could Reach $60 Per Share
Swiss health care giant Roche made a hostile bid to buy Illumina for $44.50 per share, but many think that number will be higher when all is said and done.
Do Magic Mushrooms Hold the Key to Treating Depression?
Controversial British researcher touting use of "magic mushroom" compound psilocybin in treating depression as illegal drugs move further into pharma forefront.
5 Booming Biotech And Health Care Stocks to Buy Now
These biotech and health care companies are booming with positive returns. Take advantage of one of the biggest sector trends before it's too late.
